Effects of perioperative intravenous lidocaine on postoperative sleep in patients with colorectal cancer

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038184

Enrollment

Unknown

Registered

2020-09-12

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

experimental group:Intravenous lidocaine

control group:Nil

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who underwent elective laparoscopic radical resection of colorectal cancer were aged 45-65 years old, ASA grade II ~ III, AND BMI20 ~ 30 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Allergic to local anesthetics; 2. Severe liver, kidney and heart dysfunction; 3. Patients with mental disorders; 4. Long-term use of opioids or antipsychotic drugs; 5. Patients with impaired cognitive function.

Design outcomes

Primary

Measure	Time frame
Postoperative sleep function;	—

Countries

China

Contacts

Public ContactDeng Liqin

General Hospital of Ningxia Medical University

2549597170@qq.com+86 13909511651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026